16-02-2021 16:30 via medpagetoday.com

Venetoclax-Lenalidomide Combo Effective and Safe in R/R MCL

(MedPage Today) -- At December's American Society of Hematology (ASH) virtual meeting, data from the VALERIA phase I/II trial were presented, which evaluated the efficacy and tolerability of venetoclax to the backbone of rituximab-lenalidomide...
Read more »